VP Clinical Affairs Search · Engaged Search

VP Clinical Affairs Search.

Strategic clinical leadership for health-tech, payer, life sciences, and digital health operators where clinical credibility, regulatory navigation, and product-clinical integration all matter.

Start a VP Clinical Affairs search →How engaged search works

The thesis

What this search actually requires.

VP Clinical Affairs is the role that lives at the intersection of clinical practice, product, and regulatory in health-tech, life sciences, and payer organizations. The seat owns clinical advisory, medical strategy, clinical evidence generation, and the clinical voice in product and regulatory conversations. Strong candidates are practicing or recently-practicing physicians (or senior clinical PhDs) who can hold credibility with external clinical stakeholders.

Most VP Clinical Affairs searches are engaged, sometimes retained. The candidate pool is small and almost entirely passive; the search has to surface clinical leaders who chose the operator/product path over continued full-time practice. The recruiter on your search has placed across health-tech, telehealth, payer, and digital therapeutics operators.

Compensation

VP Clinical Affairs comp ranges in 2026.

Typical 2026 ranges for the VP Clinical Affairs role. Specific comp is benchmarked per engagement against peer companies and the candidate's track record.

✓Early-stage health-tech VP Clinical Affairs: $240,000–$340,000 base, with meaningful equity
✓Growth-stage health-tech VP Clinical Affairs: $300,000–$450,000 base, plus bonus and equity
✓Public-company / PE-backed VP Clinical Affairs: $400,000–$600,000 base, plus bonus and equity
✓Total compensation typically 1.5–2.2× base for venture-backed and PE-backed operators

How the search runs

Five steps, end-to-end.

From kickoff to closed offer, run by the senior headhunter you meet on the first call.

Scoping with the CEO, CMO (where present), or Chief Product Officer; alignment on scope and external-vs-internal clinical mix
Market mapping across clinical leaders in peer operators; targeted outreach to physicians and senior clinical PhDs in the operator/product path
Calibrated shortlist (3–5 candidates) with product-clinical fit assessment and regulatory-experience screen
Working sessions with the CEO, product, regulatory, and (where applicable) clinical advisory board
Reference checks across operator and clinical networks, offer construction with equity emphasis, and close

Industries we run this in

Where the VP Clinical Affairs search lives.

The industries where this role profile shows up most often on our desk.

Industry

FAQ

VP Clinical Affairs search,
specifically.

The questions hiring leaders ask in the first scoping call.

How is VP Clinical Affairs different from CMO?

In health-tech and digital health, a VP Clinical Affairs typically reports to the CEO or Chief Product Officer and owns clinical strategy and clinical-product alignment without operational responsibility for a clinical workforce. A CMO in the same organization (where the role exists) owns the broader clinical operations and external clinical voice. In smaller operators, the two roles are often combined.

How long does a VP Clinical Affairs search take?

Engaged searches typically run 90–140 days from engagement to closed offer. Searches that require very specific therapeutic-area expertise (e.g., oncology, neurology, mental health) run longer.

Do candidates continue clinical practice?

It depends on the operator. Roughly 30–50 percent of VP Clinical Affairs placements continue light clinical practice (0.1–0.2 FTE) to maintain credentials and credibility. The other 50–70 percent are full-time-operator; many keep board certification active without clinical practice.

Is regulatory experience required?

Strongly preferred. The role frequently engages with FDA (for digital therapeutics and software-as-a-medical-device), CMS (for payer-side operators), and state-level licensure. Candidates with prior FDA submission or payer-coverage-strategy experience are highly valued.